WWW.EXFILE.COM, INC. -- 888-775-4789 -- BOSTON SCIENTIFIC CORP. -- FORM 8K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549
 
 
FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
 
Date of Report (Date of earliest event reported):     November 19, 2007

 
BOSTON SCIENTIFIC CORPORATION
(Exact name of registrant as specified in charter)

DELAWARE
1-11083
04-2695240
(State or other
(Commission
(IRS employer
jurisdiction of
file number)
identification no.)
incorporation)
    

One Boston Scientific Place, Natick, Massachusetts
01760-1537
(Address of principal executive offices)
(Zip code)

Registrant’s telephone number, including area code:  (508) 650-8000
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
ITEM 8.01.   
 OTHER EVENTS.

On November 19, 2007, we announced that an amended agreement had been reached to settle claims associated with a series of product communications issued by Guidant Corporation in 2005 and 2006. We acquired Guidant Corporation last year.  This agreement amends a prior agreement we reached in July 2007 to cover additional unanticipated claims.

Under the terms of the amended agreement, subject to certain conditions, we will pay a total of up to $240 million.  The agreement covers 8,550 patient claims, including all of those that have been consolidated in the U.S. District Court for the District of Minnesota in a Multi-District Litigation, as well as other filed and unfiled claims throughout the United States.  As a result of the amendment, proceedings in Minnesota state court have, like the trials in the bellwether cases in the MDL, been stayed.

A copy of the press release is filed as Exhibit 99.1.

 

 
 
 
ITEM 9.01.
FINANCIAL STATEMENTS AND EXHIBITS.
 
Exhibit  No.  
 Description
   
99.1  
Press release, dated November 19, 2007
 
 
 
 
 
 
 
- 2 -
 
 
SIGNATURE

Pursuant to the requirements of the Securities and Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
     
  BOSTON SCIENTIFIC CORPORATION
   
 
 		  
 		  
 
Date:       November 19, 2007 By:   /s/ Lawrence J. Knopf
 
Lawrence J. Knopf
 
Senior Vice President and Deputy General Counsel
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- 3 -

EXHIBIT INDEX
 

 
Exhibit No.
Description
 
99.1
Press release, dated November 19, 2007
   
   
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
- 4 -